Structural analysis of obscurin gene in hypertrophic cardiomyopathy

Biochemical and Biophysical Research Communications

Volumn 362, Issue 2, 2007, Pages 281-287

  Arimura, Takuro ^a   Matsumoto, Yuji ^a,b   Okazaki, Osamu ^c   Hayashi, Takeharu ^a   Takahashi, Megumi ^a   Inagaki, Natsuko ^a   Hinohara, Kunihiko ^a   Ashizawa, Naoto ^b   Yano, Keisuke ^b   Kimura, Akinori ^a  

^a Tokyo Medical and Dental University   (Japan)

^b Department of Cardiovascular Medicine   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Hypertrophic cardiomyopathy; Mutation; Obscurin; Protein protein interaction; Titin connectin

Indexed keywords

CONNECTIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN OBSCN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; CARDIOMYOPATHY, HYPERTROPHIC; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOPRECIPITATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION; MYOCYTES, CARDIAC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; SARCOMERES; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 34548312200     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.183     Document Type: Article

References (28)

1. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., and Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Maron B.J., Towbin J.A., Thiene G., Antzelevitch C., Corrado D., Arnett D., Moss A.J., Seidman C.E., and Young J.B. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006) 1807-1816
3. Frank D., Kuhn C., Katus H.A., and Frey N. The sarcomeric Z-disc: a nodal point in signalling and disease. J. Mol. Med 84 (2006) 446-468
4. Tskhovrebova L., and Trinick J. Titin: properties and family relationships. Nat. Rev. Mol. Cell. Biol. 4 (2003) 679-689
5. Granzier H.L., and Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ. Res. 94 (2004) 284-295
6. Flashman E., Redwood C., Moolman-Smook J., and Watkins H. Cardiac myosin binding protein C: its role in physiology and disease. Circ. Res. 94 (2004) 1279-1289
7. Bonne G., Carrier L., Bercovici J., Cruaud C., Richard P., Hainque B., Gautel M., Labeit S., James M., Beckmann J., Weissenbach J., Vosberg H.P., Fiszman M., Komajda M., and Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat. Genet. 11 (1995) 438-440
8. Mogensen J., Klausen I.C., Pedersen A.K., Egeblad H., Bross P., Kruse T.A., Gregersen N., Hansen P.S., Baandrup U., and Borglum A.D. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J. Clin. Invest. 103 (1999) R39-R43
9. Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., Takahashi M., Hori H., Yasunami M., Nishi H., Koga Y., Nakamura H., Matsuzaki M., Choi B.Y., Bae S.W., You C.W., Han K.H., Park J.E., Knoll R., Hoshijima M., Chien K.R., and Kimura A. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 2192-2201
10. Satoh M., Takahashi M., Sakamoto T., Hiroe M., Marumo F., and Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem. Biophys. Res. Commun. 262 (1999) 411-417
11. Itoh-Satoh M., Hayashi T., Nishi H., Koga Y., Arimura T., Koyanagi T., Takahashi M., Hohda S., Ueda K., Nouchi T., Hiroe M., Marumo F., Imaizumi T., Yasunami M., and Kimura A. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 291 (2002) 385-393
12. Inagaki N., Hayashi T., Arimura T., Koga Y., Takahashi M., Shibata H., Teraoka K., Chikamori T., Yamashina A., and Kimura A. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 342 (2006) 379-386
13. Matsumoto Y., Hayashi T., Inagaki N., Takahashi M., Hiroi S., Nakamura T., Arimura T., Nakamura K., Ashizawa N., Yasunami M., Ohe T., Yano K., and Kimura A. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J. Muscle Res. Cell Motil. 26 (2005) 367-374
14. Young P., Ehler E., and Gautel M. Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly. J. Cell Biol. 154 (2001) 123-136
15. Bang M.L., Centner T., Fornoff F., Geach A.J., Gotthardt M., McNabb M., Witt C.C., Labeit D., Gregorio C.C., Granzier H., and Labeit S. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ. Res. 89 (2001) 1065-1072
16. Kontrogianni-Konstantopoulos A., Catino D.H., Strong J.C., Sutter S., Borisov A.B., Pumplin D.W., Russell M.W., and Bloch R.J. Obscurin modulates the assembly and organization of sarcomeres and the sarcoplasmic reticulum. FASEB J. 20 (2006) 2102-2111
17. Borisov A.B., Raeker M.O., Kontrogianni-Konstantopoulos A., Yang K., Kurnit D.M., Bloch R.J., and Russell M.W. Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth. Biochem. Biophys. Res. Commun. 310 (2003) 910-918
18. Borisov A.B., Sutter S.B., Kontrogianni-Konstantopoulos A., Bloch R.J., Westfall M.V., and Russell M.W. Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing. Histochem. Cell Biol. (2005) 1-12
19. Arimura T., Hayashi T., Terada H., Lee S.Y., Zhou Q., Takahashi M., Ueda K., Nouchi T., Hohda S., Shibutani M., Hirose M., Chen J., Park J.E., Yasunami M., Hayashi H., and Kimura A. A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J. Biol. Chem. 279 (2004) 6746-6752
20. Kimura A., Harada H., Park J.E., Nishi H., Satoh M., Takahashi M., Hiroi S., Sasaoka T., Ohbuchi N., Nakamura T., Koyanagi T., Hwang T.H., Choo J.A., Chung K.S., Hasegawa A., Nagai R., Okazaki O., Nakamura H., Matsuzaki M., Sakamoto T., Toshima H., Koga Y., Imaizumi T., and Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16 (1997) 379-382
21. Schwede T., Kopp J., Guex N., and Peitsch M.C. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31 (2003) 3381-3385
22. Arimura T., Hayashi T., Matsumoto Y., Shibata H., Hiroi S., Nakamura T., Inagaki N., Hinohara K., Takahashi M., Manatsu S.I., Sasaoka T., Izumi T., Bonne G., Schwartz K., and Kimura A. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. (2007)
23. Naito H., Melnychenko I., Didie M., Schneiderbanger K., Schubert P., Rosenkranz S., Eschenhagen T., and Zimmermann W.H. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114 (2006) I72-I78
24. Nakagawa O., Ogawa Y., Itoh H., Suga S., Komatsu Y., Kishimoto I., Nishino K., Yoshimasa T., and Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J. Clin. Invest. 96 (1995) 1280-1287
25. Russell M.W., Raeker M.O., Korytkowski K.A., and Sonneman K.J. Identification, tissue expression and chromosomal localization of human Obscurin-MLCK, a member of the titin and Dbl families of myosin light chain kinases. Gene 282 (2002) 237-246
26. Sutter S.B., Raeker M.O., Borisov A.B., and Russell M.W. Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases. Dev. Genes Evol. 214 (2004) 352-359
27. Waterston R.H., Thomson J.N., and Brenner S. Mutants with altered muscle structure of Caenorhabditis elegans. Dev. Biol. 77 (1980) 271-302
28. Raeker M.O., Su F., Geisler S.B., Borisov A.B., Kontrogianni-Konstantopoulos A., Lyons S.E., and Russell M.W. Obscurin is required for the lateral alignment of striated myofibrils in zebrafish. Dev. Dyn. 235 (2006) 2018-2029